Welcome Guest from United States
Sign In Change Country
  0 Items
Search:

2008 Proteomics Seminar Tour

Seminar Series Home

Register here


Agendas and Dates:
Mon Oct 6Tours
Tue Oct 7Utrecht
Wed Oct 8Copenhagen
Thu Oct 9Stockholm
Wed Oct 15Manchester
Thu Oct 16Dublin
Fri Oct 17London
Mon Oct 20 Vienna
Tue Oct 21Munich
Wed Oct 22 Basel
Thu Oct 23 Berlin
Mon Nov 10Madrid
Wed Nov 12 Barcelona
Thu Nov 13Milan

Abstracts
• Juan Casado-Vela
Applicability of LTQ-Orbitrap MS to address proteomic studies: high-throughput protein ID, changes of protein level using iTRAQ and de novo sequencing.

• Bruno Domon
Novel Strategies Enabling High-Throughput Proteomic Analyses

• Warwick Dunn
The role of the LTQ-Orbitrap in metabolic profiling of mammalian metabolomes

• Melanie Flint
Molecular determination of stress hormone-mediated drug resistance to Paclitaxel in breast cancer

• David Good
Characterizing the Human Embryonic Stem Cell Proteome ? Life with an ETD-Enabled Orbitrap

• Claus Jorgensen
Mapping of signaling networks in boundary formation by quantitative mass spectrometry and RNAi

• Patrick Kiefer
Metabolome analysis by liquid chromatography high resolution mass spectrometry using the LTQ-Orbitrap

• Bernhard Kuester
Robust iTRAQ peptide quantification on an LTQ-Orbitrap mass spectrometer and its application to chemical proteomics

• Martin Larsen
Phosphoproteomics ? technologies and application to the study of depolarization-dependent protein phosphorylation in nerve terminals

• Matthias Mann
Towards complete proteome quantitation

• Nick Morris
The use of phosphoproteomics to discover novel AMPK substrates

• Scott Peterman
Expediting targeted protein quantitation method development using a triple quadrupole mass spectrometer: software and hardware tools to address hypothesis-based and bioinformatics-based approaches.

• Douglas Phanstiel
Characterizing the Human Embryonic Stem Cell Proteome ? Life with an ETD-Enabled Orbitrap

• Maria Prieto (Spanish)
Análisis de Imagen por Espectrometría de Masas con el MALDI LTQ XL y MALDI LTQ Orbitrap: importancia de MS3 y del rango dinámico

• Sarah Robinson
Expediting targeted protein quantitation method development using a triple quadrupole mass spectrometer: software and hardware tools to address hypothesis-based and bioinformatics-based approaches

• John Rogers
Selective Enrichment and Quantitation of Phosphoproteins and Phosphopeptides Involved in Cell Proliferation

• Vladimir Shulaev
Metabolomics technology and bioinformatics.

• Carsten Sonksen
Full sequence and PTM characterization of recombinant proteins with analytic LC-Orbitrap MS/MS, software tools and what we still need.

• Kerstin Strupat
MALDI Produced Ions Inspected with a Linear Ion Trap - Orbitrap Mass Analyzer

• Peter Verhaert
Mass Spectrometry Imaging of Neuropeptides

• Rob Vreeken
Metabolomics and metabolite profiles for phenotyping of individuals.

• Wolfram Weckwerth
Genome-wide metabolomics, proteomics and data integration: from molecule to organism

• Amy Zumwalt
Early markers of kidney transplant rejection:
Proteomic workflows for discovery and the development of non-invasive, targeted quantitation assays









Proteomics 2008 - Sarah Robinson

Expediting targeted protein quantitation method development using a triple quadrupole mass spectrometer: software and hardware tools to address hypothesis-based and bioinformatics-based approaches

Sarah Robinson1, Amol Prakash2 and Scott Peterman2

1Thermo Fisher Scientific, Boundary Way, Hemel Hempstead, HP2 7GE, UK
2Thermo Fisher scientific, River Oaks Parkway, San Jose, CA, USA

Greater emphasis has been placed on advancing proteomics studies from discovery and/or relative quantitation to validated quantitative methods in an effort to establish clinical assays. The typical workflow involves first performing discovery based experiments to identify protein expression levels that are confidently changing between a control and treated samples and generate product ion information used to sequence the precursor peptide. The difficulty arises in transferring discovery based methods directly over to validated quantitation methods since each is generally performed on separate mass spectral platforms. Low confidence has been placed on relating relative product ion abundance obtained from ion trap CID to that observed using a triple quadrupole mass spectrometer due to the difference in ion activation mechanisms and the timescale of the excitation. Thus, the only information transferred from one method to the other is protein id, peptide sequence, and the most abundant charge state resulting in further method development to complete the SRM assay. Common approaches to determine SRM transitions are based on a set of accepted rules to determine the best possible ion pair, which is then searched against the matrix database to determine the uniqueness of each mass pair. We contend that the relative abundance of product ions originating from ion trap CID can be used to directly assign the most sensitive ion pairs for the targeted SRM methods.

The workflow presented demonstrates an effective methodology for transitioning discovery/relative protein quantitation experiments to targeted protein quantitation on a triple quadrupole mass spectrometer. We will present direct comparison of relative product ion abundance measurements for 100 plasma peptides between an ion trap and a triple quadrupole mass spectrometer. The selected peptides are broken down into sequence length ranging from 7 to 23 residues to determine consistency across the typical biomarker properties. Success rates for matching the most abundant product ions from each method to those predicted will be consolidated and reported. In addition, means to perform verification using SRM assays will be discussed.